SLC5A12 Antibodies

Santa Cruz Biotechnology provides a broad selection of SLC5A12 monoclonal antibodies for research focused on understanding SLC5A12 protein function. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SLC5A12, also known as sodium-dependent glucose transporter 2 (SGLT2), plays a crucial role in glucose reabsorption in the kidneys and is essential for maintaining glucose homeostasis. Dysregulation of SLC5A12 has been implicated in metabolic disorders, making it a significant target for therapeutic interventions. Understanding the function and regulation of SLC5A12 continues to be a key focus in diabetes research and related conditions. Recent studies have highlighted SLC5A12's importance in cellular glucose uptake mechanisms. Ongoing research explores SLC5A12's potential as a therapeutic target in various metabolic conditions. Current investigations are uncovering new aspects of SLC5A12's role in maintaining cellular energy balance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SLC5A12's role in human health and disease.